Neoantigens Market Size ($10,54,783.54 Thousand by 2028) Growth Forecast at 31.2% CAGR During 2023 to 2028 COVID Impact and Global Analysis by TheInsightPartners.com
October 07, 2021 10:16 ET | The Insight Partners
New York, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Neoantigens Market: Key InsightsAccording to our new research study on “Neoantigens Market to 2028 – Global Analysis and Forecast – by Treatment and...
Global $892 Mn Clinical Oncology Next Generation Sequencing Markets to 2028 by Technology (WGS, WES) & Application (Screening, Companion Diagnostics)
October 04, 2021 10:53 ET | Research and Markets
Dublin, Oct. 04, 2021 (GLOBE NEWSWIRE) -- The "Global Clinical Oncology Next Generation Sequencing Market 2021-2028" report has been added to ResearchAndMarkets.com's offering. The global clinical...
Annabelle Gurwitch and chef Amar Santana partner with Lung Cancer Foundation of America (LCFA) for Day at the Chef’s Table in support of lung cancer research
September 22, 2021 05:03 ET | Lung Cancer Foundation of America
Los Angeles, CA, Sept. 22, 2021 (GLOBE NEWSWIRE) -- New York Times bestselling author, actor, and activist, and former Dinner and a Movie host Annabelle Gurwitch is teaming up with celebrity chef...
Straits Research Logo.png
Cancer and Allied Advancements in Chemotherapy – Straits Research
September 16, 2021 09:00 ET | Straits Research
New York, US, Sept. 16, 2021 (GLOBE NEWSWIRE) -- The chemotherapy market is expected to grow at a compound annual growth rate (CAGR) of 10.4% in the forecast period from 2020 to 2029. The global...
Aprea logo 445pt.png
Aprea Therapeutics to Present Data from Phase 1/2 Trial of Eprenetapopt in Advanced Solid Tumors at ESMO Congress 2021
September 14, 2021 08:00 ET | Aprea Therapeutics
BOSTON, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate...
First Seven Days Spanish language podcast gives newly-diagnosed lung cancer patients potentially life-saving guidance from Lung Cancer Foundation of America
September 07, 2021 05:03 ET | Lung Cancer Foundation of America
Los Angeles, CA, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Imagine a doctor saying: “You have lung cancer.” What do you do? Who do you talk to? How do you comprehend the complicated new language of cancer?...
Lung Cancer Screening Market to Reach USD 4.85 Billion by 2028; Medtronic Acquires Koninklijke Philips N.V to Bolster its Global Position: Fortune Business Insight™
August 30, 2021 05:45 ET | Fortune Business Insights
Pune, India, Aug. 30, 2021 (GLOBE NEWSWIRE) -- The global lung cancer screening market size was USD 2.61 billion in 2020. The market is projected to grow from USD 2.80 billion in 2021 to USD 4.85...
Global $196.96 Bn Oncology Devices Market to 2025 & 2030: Major Players are Eckert & Ziegler BEBIG, Oncura, GE, Medtronic, Varian Medical Systems, Elekta, Theragenics, Accuray, and Roche Diagnostics
August 20, 2021 06:08 ET | Research and Markets
Dublin, Aug. 20, 2021 (GLOBE NEWSWIRE) -- The "Oncology Devices Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The global...
Coherus BioSciences, Inc. logo
Coherus and Junshi Biosciences Announce Positive Interim Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer
August 18, 2021 18:41 ET | Coherus BioSciences, Inc.
– Toripalimab plus chemotherapy met primary endpoint with significant improvement in PFS compared to chemotherapy alone – - Data support the use of toripalimab with chemotherapy as first-line therapy...
20170406 Telix Logo.png
Telix Progresses Novel Lung and Ovarian Cancer Theranostic APOMAB®
August 16, 2021 20:03 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and ADELAIDE, Australia, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announces it has extended its previously...